GUJTHEM430.00

Gujarat Themis Biosyn Limited

· Pharma & Health
₹ CrorePeersRPGLIFEGUFICBIOORCHPHARMAUNICHEMLABFDCIOLCPMOREPENLABINNOVACAPMcap ₹4,685 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation5.712.9
+ Finance Costs0.42.9
+ Interest Income-0.70.0
+ Fair Value (Gains) / Losses-0.20.0
+ Unrealised FX (Gain) / Loss-0.1-0.2
+ Other Non-cash Items0.0-0.1
Changes in Working Capital
+ Inventories-1.7-10.4
+ Trade Receivables — Current-4.2-29.7
+ Other Financial Assets — Current0.01.4
+ Other Financial Assets — Non-current50.8-4.0
+ Other Non-current Assets-14.20.0
+ Other Bank Balances0.8-2.1
+ Trade Payables — Current0.022.2
+ Trade Payables — Non-current4.80.0
+ Other Financial Liabilities — Current0.02.5
+ Other Financial Liabilities — Non-current1.11.7
+ Other Current Liabilities-0.50.0
+ Provisions — Current0.00.5
+ Provisions — Non-current0.10.0
Cash from Operating Activities
Profit Before Tax (per I/S)65.562.1
+ Total Adjustments (incl. Working Capital)42.0-2.3
Cash from Operations (pre-tax)107.559.8
+ Interest Received — Operating0.0-0.4
+ Income Taxes Paid16.510.6
Cash from Operating Activities91.048.8
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)116.2172.5
+ Loans & Advances Repaid-0.0-0.0
+ Interest Received — Investing4.30.3
Cash from Investing Activities-111.8-172.3
Cash from Financing Activities
+ Proceeds from Borrowings29.9130.0
+ Payment of Lease Liabilities1.61.3
+ Interest Paid0.46.4
+ Dividends Paid1.87.3
Cash from Financing Activities26.0114.9
Net Changes in Cash (pre-FX)5.2-8.6
Net Changes in Cash5.2-8.6
Reference Items
EBITDA68.875.5
EBITDA Margin %45.6545.55
Free Cash Flow (CFO − Capex)-25.1-123.8
Free Cash Flow to Equity-0.2
Free Cash Flow per Basic Share-2.31-11.36
Cash Flow to Net Income1.871.04
Cash Paid for Taxes16.510.6
Cash Paid for Interest0.46.4
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.